Curative Biotechnology Inc SEC filings CUBT

Curative Biotechnology Inc has 51 filings in SEC EDGAR's recent list, going back to May 9, 2007. The company's fiscal year ends on December 31.

Curative Biotechnology Inc SEC filings
Form Description Filed Period
S-1/A Amended registration statement Aug 1, 2025 —
S-1 Registration statement May 6, 2024 —
S-1/A Amended registration statement Jan 25, 2023 —
S-1/A Amended registration statement Jan 13, 2023 —
S-1/A Amended registration statement Jan 9, 2023 —
S-1/A Amended registration statement Nov 30, 2022 —
S-1/A Amended registration statement Nov 16, 2022 —
S-1 Registration statement Nov 7, 2022 —
S-1/A Amended registration statement Sep 30, 2022 —
S-1/A Amended registration statement Sep 28, 2022 —
S-1/A Amended registration statement Sep 9, 2022 —
S-1/A Amended registration statement Sep 1, 2022 —
S-1/A Amended registration statement Aug 10, 2022 —
S-1/A Amended registration statement Aug 1, 2022 —
S-1/A Amended registration statement Jul 8, 2022 —
S-1/A Amended registration statement Jun 29, 2022 —
S-1/A Amended registration statement Apr 25, 2022 —
S-1 Registration statement Apr 15, 2022 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CUBT (OTC)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Boca Raton, FL
SEC CIK
1400271
Former names
Connectyx Technologies Corp (until Oct 13, 2009)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.